Direct Oral Anticoagulants: CBR Researchers Join the Action
While saving countless lives, conventional anticoagulants require frequent injections and regular doctor visits to monitor clotting parameters. However, treatment options are changing with the emergence of a new generation of anticoagulants – direct oral anticoagulants (DOACs).
Interview with an alumnus of the CBR Summer Studentship Program
Meet Mike Nosella – a CBR summer student turned Co-Op from Strynadka lab. “Though it was really cool to see the huge repertoire of equipment and gadgets available to my disposal, I would have to say what was most surprising is the degree of freedom…”
Kelly McNagny joins CDRD as a new Co-Scientific Director
“We are very fortunate to have Dr. McNagny join the organization. His deep experience and scientific expertise, particularly in the area of stem cell biology will allow us to bring added value to our stakeholders. We have collaborated with him on individual projects for several years, and now look forward to having him take on this expanded role as a part of our Executive Team.”
Nichollas Scott: profile of a CBR researcher
Nichollas’ curiosity for the biological mechanisms of protein modification led him to his current research path, beginning with a PhD project at the Cordwell Laboratory at the University of Sydney, Australia.
Dr. Pryzdial gave Plenary Abstract Presentation at CSTM
Dr. Ed Pryzdial gave a Plenary Abstract Presentation at the Canadian Society for Blood Transfusion (CSTM) conference after winning one of the top two abstracts. Dr. Pryzdial’s talk was titled: “Production of infectious dengue virus by platelets”.
Dr. Dana Devine wins the CSTM ORTHO award
Canadian Society for Transfusion Medicine (CSTM) ORTHO award recognized Dr. Devine for her longstanding research career in blood products, transfusion medicine, platelet biology, complement biochemistry, and coagulation.
Dr. Strynadka elected as a Fellow to the Royal Society
Dr. Strynadka’s agenda-setting dissection of the membrane assemblies involved in infection, virulence and bacterial cell wall synthesis is having major impact in the development of therapeutic agents; both antibiotics and vaccines.
The Green Side of CBR
On February 12, 2015, Dr. Reinhild Kappelhoff, member of the CBR’s Overall Lab, won the 2015 Green Labs Fund for the project “Lancer Dishwasher 100-hole pipette rack”. It’s not the first time that CBR has won a Green Labs initiative…
Dr. Rafi Chapanian – Reflections of a Postdoc
Dr. Rafi Chapanian has recently joined Eupraxia Pharmaceuticals Inc. as a Staff Scientist. Eupraxia is a Vancouver based company dedicated to providing best-in-class treatment for some of the most prevalent diseases in the Western world, including arthritis and chronic pain. Coming from a Material Science and Engineering background, completing a postdoctorate at CBR had a […]
Michael Yuchi receives the 2014 Michael John Page PDF Award
On Friday, October 17, 2014, at a well-attended ceremony at the Life Sciences Centre at UBC, the Department of Biochemistry & Molecular Biology and the Centre for Blood Research (CBR) presented the Michael John Page Postdoctoral Fellow Award to Dr. Michael Yuchi. Michael Yuchi was born in China, starting his science career at Fudan University, […]